Older people living with HIV on successful treatment have increased levels of immunosenescence, with men who have sex with men displaying the highest levels

Background Increased immunosenescence, characterized by T- and natural killer (NK)-cell dysfunctions, is suspected among people living with HIV (PWH). The aim of this study was to explore markers of immunosenescence in older PWH receiving modern integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART) and their associated risk factors. Methods We performed a cross-sectional study comparing successfully treated PWH followed in Nice, France, with age-matched healthy HIV-negative subjects. Senescence markers were assessed on CD4+ and CD8+ T cells (KLRG1+CD57+) and NK cells (KLRG1+ and KLRG1+CD56+ bright ), along with markers of cellular activation on T cells (CD4+DR+38+ and CD8+DR+38+). We correlated immunosenescence and activation markers with background characteristics and comorbid conditions. Results From 2023 to 2024, 93 PWH receiving INSTI-based ART were included (mean age 63 years, 78% men, time since HIV infection 27 years, CD4 nadir < 200 cells/mm 3 in 46%) and 10 HIV-negative controls. Flow cytometric analysis showed that PWH had higher total, senescent, and activated CD8+ T cells than uninfected subjects. Among PWH, those older than 60 years had higher senescent CD8+ cells, while senescent NK cells increased from the age of 50. After adjustments, men who have sex with men (MSM) had higher senescent CD4+ (coefficient = 1.01, p = 0.006) and senescent CD8+ T cells (coefficient = 0.32, p = 0.04), the latter also being associated with age (coefficient = 0.03, p = 0.002), in contrast with senescent CD4+ cells (coefficient = 0.02, p = 0.403). NK senescence was associated with both MSM status (coefficient = 0.39, p = 0.044) and age (coefficient = 0.03, p = 0.001). Conclusions We found increased markers of immunosenescence among older PWH receiving modern INSTI-based ART, mainly among MSM; further prospective studies are required.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-16
DOI
https://doi.org/10.3389/fimmu.2026.1910974
Primary Topic
HIV Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Older people living with HIV on successful treatment have increased levels of immunosenescence, with men who have sex with men displaying the highest levels

Michel Ticchioni, Amandine Pisoni, Sara Ferrando, Jacqueline Capeau et al.
4 links
Frontiers in Immunology
HIV Research and Treatment
article

Older people living with HIV on successful treatment have increased levels of immunosenescence, with men who have sex with men displaying the highest levels

Michel Ticchioni, Amandine Pisoni, Sara Ferrando, Jacqueline Capeau, David Chirio, Michel Carlès, Christian Pradier, Édouard Tuaillon, Matteo Vassallo, Éric Cua, Alissa Naqvi, Jacques Durant, Maeva Godemert, Leslie Ameil, Anaelle Bisch, Roxane Fabre, Sami Addou
article en

Abstract

Background Increased immunosenescence, characterized by T- and natural killer (NK)-cell dysfunctions, is suspected among people living with HIV (PWH). The aim of this study was to explore markers of immunosenescence in older PWH receiving modern integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART) and their associated risk factors. Methods We performed a cross-sectional study comparing successfully treated PWH followed in Nice, France, with age-matched healthy HIV-negative subjects. Senescence markers were assessed on CD4+ and CD8+ T cells (KLRG1+CD57+) and NK cells (KLRG1+ and KLRG1+CD56+ bright ), along with markers of cellular activation on T cells (CD4+DR+38+ and CD8+DR+38+). We correlated immunosenescence and activation markers with background characteristics and comorbid conditions. Results From 2023 to 2024, 93 PWH receiving INSTI-based ART were included (mean age 63 years, 78% men, time since HIV infection 27 years, CD4 nadir < 200 cells/mm 3 in 46%) and 10 HIV-negative controls. Flow cytometric analysis showed that PWH had higher total, senescent, and activated CD8+ T cells than uninfected subjects. Among PWH, those older than 60 years had higher senescent CD8+ cells, while senescent NK cells increased from the age of 50. After adjustments, men who have sex with men (MSM) had higher senescent CD4+ (coefficient = 1.01, p = 0.006) and senescent CD8+ T cells (coefficient = 0.32, p = 0.04), the latter also being associated with age (coefficient = 0.03, p = 0.002), in contrast with senescent CD4+ cells (coefficient = 0.02, p = 0.403). NK senescence was associated with both MSM status (coefficient = 0.39, p = 0.044) and age (coefficient = 0.03, p = 0.001). Conclusions We found increased markers of immunosenescence among older PWH receiving modern INSTI-based ART, mainly among MSM; further prospective studies are required.

Frontiers in ImmunologyVol. 17
Inserm (FR), Université de Montpellier (FR), Université Côte d'Azur (FR), Centre Hospitalier Universitaire de Nice (FR), Sorbonne Université (FR), Centre Hospitalier Universitaire de Montpellier (FR), Centre de Recherche Saint-Antoine (FR), Centre Hospitalier de Cannes (FR), Fondation pour l’innovation en Cadiométabolisme et Nutrition (FR), Unité de Recherche Clinique Côte d'Azur (FR), Pathogenesis and Control of Chronic and Emerging Infections (FR)
Gilead Sciences
Good health and well-being
HIV Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon